Home/Filings/4/0001209191-15-029054
4//SEC Filing

AMICUS THERAPEUTICS INC 4

Accession 0001209191-15-029054

$FOLDCIK 0001178879operating

Filed

Mar 23, 8:00 PM ET

Accepted

Mar 24, 9:52 PM ET

Size

13.9 KB

Accession

0001209191-15-029054

Insider Transaction Report

Form 4
Period: 2015-03-20
Peist Kenneth
VP, Intellectual Property
Transactions
  • Sale

    Common stock

    2015-03-20$11.52/sh10,000$115,16050,000 total
  • Exercise/Conversion

    Stock Options (right to buy)

    2015-03-202,50018,647 total
    Exercise: $3.53From: 2014-01-28Exp: 2023-01-28Common Stock (2,500 underlying)
  • Exercise/Conversion

    Stock Options (right to buy)

    2015-03-205,00045,000 total
    Exercise: $2.45From: 2015-01-03Exp: 2024-01-03Common stock (5,000 underlying)
  • Exercise/Conversion

    Stock Options (right to buy)

    2015-03-202,50022,292 total
    Exercise: $2.52From: 2014-06-18Exp: 2023-06-18Common stock (2,500 underlying)
  • Exercise/Conversion

    Common stock

    2015-03-20$11.52/sh+10,000$115,16060,000 total
Footnotes (3)
  • [F1]The exercise of stock options and subsequent sale of common stock were made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 17, 2014.
  • [F2]This price is the weighted average purchase price for the transactions reported on this line. The prices for the transactions reported on this line range from $11.17 to $11.95. The reporting person undertakes to provide, upon request, by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased at each separate price.
  • [F3]This price is the weighted average sale price for the transactions reported on this line. The prices for the transactions reported on this line range from $11.17 to $11.95. The reporting person undertakes to provide, upon request, by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price.

Issuer

AMICUS THERAPEUTICS INC

CIK 0001178879

Entity typeoperating
IncorporatedDE

Related Parties

1
  • filerCIK 0001178879

Filing Metadata

Form type
4
Filed
Mar 23, 8:00 PM ET
Accepted
Mar 24, 9:52 PM ET
Size
13.9 KB